Curve Bg

Apogee Therapeutics is a clinical stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology markets, including for the treatment of atopic dermatitis asthma, chronic obstructive pulmonary disease, eosinophilic esophagitis and other I&I indications.

Close-up of photo of an infant showing the bottom half of the face with atopic dermatis rash

Refusing to stop at Left Quotegood enoughRight Quote

Apogee is seeking to reshape the current standard of care for inflammatory and immune diseases because we believe people living with these diseases deserve the best possible treatment.

Our pipeline of novel antibody therapeutics targets well-established biological drivers and development pathways and has the potential to treat numerous dermatological, respiratory, and gastroenterological conditions.

Photograph looking through a glass window into a conference room with Apogee team members sitting around a table

Our Team

Our seasoned team of skilled drug developers and operators are driven by the desire to give better treatment options to people living with inflammatory and immune diseases.

People first, always

Careers

We strongly believe the best thing we can do for fellow teammates and people living with inflammatory and immune diseases is to create an environment of psychological safety, where everyone feels comfortable sharing different ideas and ultimately coming to the best answer together.